Bicocca Open Archive

Logo unimib boa
BIAGI, ETTORE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.361
EU - Europa 3.856
AS - Asia 1.886
SA - Sud America 105
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 7
Totale 16.250
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.198
SG - Singapore 709
SE - Svezia 689
CN - Cina 634
RU - Federazione Russa 588
DE - Germania 576
UA - Ucraina 482
IE - Irlanda 465
IT - Italia 425
HK - Hong Kong 289
GB - Regno Unito 207
CA - Canada 151
FI - Finlandia 116
VN - Vietnam 92
BR - Brasile 90
FR - Francia 66
TR - Turchia 54
AT - Austria 46
BE - Belgio 45
IN - India 44
NL - Olanda 43
DK - Danimarca 37
BG - Bulgaria 20
ID - Indonesia 13
JP - Giappone 13
EU - Europa 10
IR - Iran 10
MX - Messico 10
RO - Romania 9
ZA - Sudafrica 8
CH - Svizzera 7
ES - Italia 7
PL - Polonia 6
AU - Australia 5
IL - Israele 5
IQ - Iraq 5
KR - Corea 5
CZ - Repubblica Ceca 4
EG - Egitto 4
MU - Mauritius 4
AL - Albania 3
CL - Cile 3
EC - Ecuador 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CO - Colombia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
TW - Taiwan 2
VE - Venezuela 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 16.250
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.605
Woodbridge 1.238
Fairfield 876
Houston 810
Chandler 724
Wilmington 691
Ashburn 569
Jacksonville 516
Dublin 456
Singapore 420
Seattle 377
Cambridge 335
Frankfurt am Main 333
Dearborn 316
Hong Kong 286
Princeton 194
New York 174
Santa Clara 154
Nanjing 133
Milan 122
Lawrence 85
Shanghai 84
Lachine 83
Beijing 69
Altamura 68
Dong Ket 60
San Diego 47
Vienna 44
Brussels 43
Nanchang 38
Council Bluffs 37
Toronto 36
Boardman 35
Moscow 35
Andover 33
Lissone 33
Helsinki 31
Tianjin 31
Fremont 30
Los Angeles 28
Shenyang 28
Hebei 27
Mountain View 26
Guangzhou 24
Huizen 23
Hangzhou 20
Plovdiv 20
Jinan 18
Changsha 17
Ningbo 17
Ottawa 16
Jiaxing 15
Rome 15
Falls Church 14
Kocaeli 14
Nürnberg 14
Zhengzhou 14
Auburn Hills 13
London 13
University Park 13
Dallas 12
Edmonton 12
Norwalk 12
São Paulo 12
Philadelphia 11
Chicago 10
Jakarta 10
Taizhou 10
Kunming 9
Contursi 8
Detroit 8
Munich 8
Nuremberg 8
Washington 8
Düsseldorf 7
Hefei 7
Portsmouth 7
Redmond 7
Brooklyn 6
Monza 6
Padova 6
Bergamo 5
Brescia 5
Madrid 5
Rio de Janeiro 5
San Mateo 5
Stockholm 5
Tappahannock 5
The Dalles 5
Cuauhtémoc 4
Florence 4
Hanoi 4
Missaglia 4
Napoli 4
Amsterdam 3
Baghdad 3
Bonndorf 3
Brno 3
Cairo 3
Cardano al Campo 3
Totale 11.902
Salva come PNG Salva come JPEG
Nome #
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 342
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 330
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 307
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 295
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 274
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 271
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 268
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 267
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 267
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 262
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 248
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 245
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 243
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 239
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 236
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 227
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 224
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 218
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 217
Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells 216
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 214
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 212
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 211
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 208
Chimeric T-cell receptors: New challenges for targeted immunotherapy in hematologic malignancies 202
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors 201
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 199
Characterization of Plated Lysate Cultured Mesenchymal Stromal Cells and Their Potential Use in Tissue-Engineered Osteogenic Devices for the Treatment of Bone Defects 194
Long-term effects of bone marrow transplantation on dental status in children with leukaemia 194
Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes 193
Upregulation of Adhesion Molecules on Leukemia Targets Improves the Efficacy of Cytotoxic T Cells Transduced With Chimeric Anti-CD19 Receptor 191
Chimeric Antigen Receptors against CD33/CD123 antigens efficiently target primary Acute Myeloid Leukemia cells in vivo 188
GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy 184
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives 183
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia 183
TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission 182
Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease 181
Donor-derived CD19-targeted T cells in allogeneic transplants 180
Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine 179
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor 178
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor 178
Comparison of different suicide-gene strategies for the safety improvement of genetically manipulated T cells 175
Antigen-induced regulatory T cells 174
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 173
Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience 172
Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library 171
Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells 171
Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cells 171
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis 169
CD40 activation of BCP-ALL cells generates 11L-10-producing, 11L-12-defective APCs that induce allogeneic T-cell anergy 167
Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device 166
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 166
Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes 164
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia 162
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation. 160
Chimeric Antigen Receptor for Specific Targeting of Acute Myeloid Leukemia 159
A life-threatening paediatric case of acute autoimmune haemolytic anaemia (AIHA) successfully cured by plasma-exchange and combined immunosuppressive treatment 158
Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia 158
Development of an alveolar bone regeneration protocol with mesenchyl stem cells for the therapy of severe bone resorption in periodontal disease 156
Role of early diagnosis for a noninvasive treatment of pulmonary thromboembolism in leukemic children 156
Intrathecal chemotherapy with antineoplastic agents in children 154
Cytokine Induced Killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors 153
Cell-based strategies to manage leukemia relapse: Efficacy and feasibility of immunotherapy approaches 151
Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain 149
Estudio experimental sobre la utilización de células madre humanas en la terapia de los defectos periodontales: resultados preliminares 148
Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies 148
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 148
Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells 146
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis 145
PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patients. 144
A persistent severe autoimmune hemolytic anemia despite apparent direct antiglobulin test negativization 143
Prolonged extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome in a child affected by rituximab-resistant autoimmune hemolytic anemia: A case report 140
Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedside 140
T lymphocytes redirected against the κ light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells 138
From Bone Marrow Transplantation to Cellular Therapies: Possible therapeutic strategies in managing autoimmune disorders 135
Effectiveness of extracorporeal photochemotherapy in treating long-term refractory chronic graft-versus-host disease 134
CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia 127
The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs 126
New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future 126
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression. Mol Cancer 125
In Vitro Comparison of Three Different Chimeric Receptor-modified Effector T-cell Populations for Leukemia Cell Therapy 121
A Phase 1/2 Study of Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 in Patients With High-risk Neuroblastoma 117
In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33 Acute Myeloid Leukemia 116
LONG TERM SURVIVAL AND EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT DEPENDENT ON IMMUNOSUPPRESSIVE TREATMENT. 116
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor 114
Phase I Trial of Vaccination With Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 and Lymphotactin 114
Long term efficacy of human bone marrow mesenchymal stem cells in traumatized mice brain is not affected by immunosuppressive treatment 110
New findings about the Interplay among Clarithromycin, Immune and Central Nervous Systems 103
Rapid and efficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cells 101
Mesenchymal stem/stromal cells: a new "cells as drugs" paradigm. Efficacy and critical aspects in cell therapy 100
LONG TERM EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT AFFECTED BY IMMUNOSUPPRESSIVE TREATMENT. 85
null 78
LONG TERM EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT AFFECTED BY IMMUNOSUPPRESSIVE TREATMENT. 74
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo 64
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia 50
Totale 16.662
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020378 0 0 0 0 0 0 0 0 0 131 182 65
2020/20212.003 120 164 292 204 139 138 166 124 153 223 85 195
2021/20221.376 51 135 208 106 71 68 58 66 138 134 98 243
2022/20232.370 271 739 198 224 136 355 24 151 171 6 69 26
2023/20241.359 46 39 61 56 202 348 264 62 112 8 30 131
2024/20252.217 185 333 135 141 255 74 140 116 385 453 0 0
Totale 16.662